SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-071435
Filing Date
2024-06-10
Accepted
2024-06-10 17:26:43
Documents
3
Period of Report
2024-06-10

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1574
2 EX-24 pyxs-ex24.htm EX-24 12800
3 GRAPHIC img76230289_0.jpg GRAPHIC 6763
  Complete submission text file 0000950170-24-071435.txt   25252
Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, WALTHAM MA 02451
Business Address
Metzger Michael A (Reporting) CIK: 0001507220 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40881 | Film No.: 241033870

Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)